Molecular AssaysqPCRRUO

Leukemia Fusion Genes (Q55)Screening Kit

By Zeesan Biotech (致善生物)

Product TypeAssay Kit
TechnologyqPCR
Regulatory StatusRUO
Sample TypesWhole Blood
Leukemia Fusion Genes (Q55)Screening Kit — Zeesan Biotech (致善生物) product image

Key takeaways

Leukemia Fusion Genes (Q55)Screening Kit is a product in the Molecular Assays category, manufactured by Zeesan Biotech (致善生物). Listed regulatory status: RUO (as reported by the manufacturer).

  • Platform: qPCR
  • Sample types: whole blood

Classification

Category
Molecular Assays
Product Type
Assay Kit
Technology
qPCR

Workflow

Sample Types
Whole Blood

Regulatory Status

RUO

Reported from manufacturer sources and not independently verified.

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

  • The Leukemia Fusion Genes (Q55) Screening Kit is a qualitative multiplex assay developed to detect 55 leukemia-associated genes.
    Zeesan Biotech (致善生物)Product TypeManufacturer Page2026-10-31
  • Leukemia Fusion Genes (Q55)Screening Kit is a multiplex RT-qPCR based assay for detection of the 55 leukemia-associated genes transcripts including EVI1, HOX11, HOX11L2 and 52 fusion genes in total RNA from human bone marrow or peripheral whole blood samples.
    Zeesan Biotech (致善生物)Technology PlatformManufacturer Page2026-10-31
  • The kit utilizes an RT-qPCR procedure to detect RNA transcripts of fusion genes extracted from human bone marrow or peripheral whole blood samples.
    Zeesan Biotech (致善生物)Sample TypesManufacturer Page2026-10-31

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-17

Updated

2026-10-31

Disclaimer

availability varies

Explore more